Available data show that the burden of JAK2 V617F alleles could correlate with the phenotypic presentation of MPN [4], severity of the disease phenotype [5], the risk of thrombotic events [6, 7], progression to post-PV myelofibrosis [8], and survival [9]. This evidence concerns the gene JAK2 and acquired polycythemia vera.